New combo vaccine for whooping cough, diphtheria, and tetanus enters early human testing
NCT ID NCT07492303
First seen Mar 25, 2026 · Last updated May 01, 2026 · Updated 2 times
Summary
This early-stage study tests a new vaccine that protects against whooping cough, diphtheria, and tetanus in people aged 10 and older. Researchers will check if different doses are safe and trigger a strong immune response. About 96 volunteers will receive either the vaccine or a placebo, and be monitored for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.